Latest Insider Transactions at Cti Biopharma Corp (CTIC)
This section provides a real-time view of insider transactions for Cti Biopharma Corp (CTIC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CTI BIOPHARMA CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CTI BIOPHARMA CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 26
2023
|
Bvf Partners L P Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
1,569,286
-100.0%
|
$14,123,574
$9.1 P/Share
|
|
Jun 26
2023
|
Bvf Partners L P Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
7,286,874
-100.0%
|
$65,581,866
$9.1 P/Share
|
|
Jun 26
2023
|
James K Fong EVP & Chief Commercial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,565
-100.0%
|
$32,085
$9.1 P/Share
|
|
Jun 26
2023
|
Adam R Craig President and CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
31,470
-100.0%
|
$283,230
$9.1 P/Share
|
|
Jun 26
2023
|
David Kirske EVP, Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
17,547
-100.0%
|
$157,923
$9.1 P/Share
|
|
Jun 26
2023
|
Reed Vaughn Tuckson Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
48,639
-100.0%
|
$437,751
$9.1 P/Share
|
|
Jun 26
2023
|
Matthew D Perry Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
43,139
-100.0%
|
$388,251
$9.1 P/Share
|
|
Jan 24
2023
|
Adam R Craig President and CEO |
SELL
Open market or private sale
|
Direct |
85,317
-40.29%
|
$511,902
$6.01 P/Share
|
|
Jan 24
2023
|
Adam R Craig President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
85,317
+24.39%
|
$0
$0.84 P/Share
|
|
Jan 24
2023
|
James K Fong EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
100,000
-96.56%
|
$600,000
$6.0 P/Share
|
|
Jan 24
2023
|
James K Fong EVP & Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+49.12%
|
$0
$0.95 P/Share
|
|
Jan 03
2023
|
Adam R Craig President and CEO |
SELL
Open market or private sale
|
Direct |
84,683
-74.2%
|
$508,098
$6.01 P/Share
|
|
Jan 03
2023
|
Adam R Craig President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
84,683
+42.6%
|
$0
$0.84 P/Share
|
|
Jan 03
2023
|
David Kirske EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
27,021
-61.21%
|
$162,126
$6.01 P/Share
|
|
Jan 03
2023
|
David Kirske EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,021
+37.97%
|
$0
$0.95 P/Share
|
|
Dec 30
2022
|
Adam R Craig President and CEO |
SELL
Open market or private sale
|
Direct |
17,100
-14.76%
|
$102,600
$6.0 P/Share
|
|
Dec 30
2022
|
Adam R Craig President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,100
+12.08%
|
$0
$0.84 P/Share
|
|
Dec 30
2022
|
Adam R Craig President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,579
+5.09%
|
$7,895
$5.11 P/Share
|
|
Dec 30
2022
|
David Kirske EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,847
-17.14%
|
$83,082
$6.0 P/Share
|
|
Dec 30
2022
|
David Kirske EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,847
+12.97%
|
$0
$0.95 P/Share
|
|
Dec 30
2022
|
David Kirske EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
214
+1.23%
|
$1,070
$5.11 P/Share
|
|
Dec 29
2022
|
Adam R Craig President and CEO |
SELL
Open market or private sale
|
Direct |
13,800
-33.12%
|
$82,800
$6.0 P/Share
|
|
Dec 29
2022
|
Adam R Craig President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,800
+24.88%
|
$0
$0.84 P/Share
|
|
Dec 29
2022
|
David Kirske EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,174
-43.79%
|
$79,044
$6.0 P/Share
|
|
Dec 29
2022
|
David Kirske EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,174
+30.45%
|
$0
$0.95 P/Share
|
|
Nov 10
2022
|
Adam R Craig President and CEO |
SELL
Open market or private sale
|
Direct |
188,304
-21.85%
|
$1,129,824
$6.02 P/Share
|
|
Nov 10
2022
|
Adam R Craig President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
188,304
+46.56%
|
$0
$0.84 P/Share
|
|
Nov 09
2022
|
Adam R Craig President and CEO |
SELL
Open market or private sale
|
Direct |
53,996
-26.21%
|
$323,976
$6.01 P/Share
|
|
Nov 09
2022
|
Adam R Craig President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
53,996
+39.75%
|
$0
$0.84 P/Share
|
|
Nov 08
2022
|
Michael A Metzger Director |
SELL
Open market or private sale
|
Direct |
91,500
-81.28%
|
$457,500
$5.63 P/Share
|
|
Nov 08
2022
|
Michael A Metzger Director |
BUY
Exercise of conversion of derivative security
|
Direct |
91,500
+45.39%
|
$0
$0.92 P/Share
|
|
Oct 04
2022
|
David Kirske EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,109
-3.9%
|
$12,654
$6.26 P/Share
|
|
Oct 04
2022
|
David Kirske EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,109
+3.68%
|
$0
$0.95 P/Share
|
|
Oct 03
2022
|
David Kirske EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
300
-1.74%
|
$1,800
$6.25 P/Share
|
|
Oct 03
2022
|
David Kirske EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+1.71%
|
$0
$0.95 P/Share
|
|
Sep 30
2022
|
David Kirske EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
139,841
-89.21%
|
$839,046
$6.05 P/Share
|
|
Sep 30
2022
|
David Kirske EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
139,841
+47.15%
|
$0
$0.95 P/Share
|
|
Sep 29
2022
|
David Kirske EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
900
-2.55%
|
$5,400
$6.01 P/Share
|
|
Sep 29
2022
|
David Kirske EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+2.45%
|
$0
$0.95 P/Share
|
|
Sep 16
2022
|
David Kirske EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,592
-57.19%
|
$135,552
$6.02 P/Share
|
|
Sep 16
2022
|
David Kirske EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,592
+36.38%
|
$0
$0.95 P/Share
|
|
Sep 12
2022
|
Adam R Craig President and CEO |
SELL
Open market or private sale
|
Direct |
242,300
-89.69%
|
$1,453,800
$6.43 P/Share
|
|
Sep 12
2022
|
Adam R Craig President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
242,300
+47.28%
|
$0
$0.84 P/Share
|
|
Aug 16
2022
|
Adam R Craig President and CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+15.22%
|
$25,000
$5.5 P/Share
|
|
Aug 09
2022
|
Bvf Partners L P Director |
BUY
Conversion of derivative security
|
Indirect |
1,519,999
+49.9%
|
-
|
|
Aug 09
2022
|
Bvf Partners L P Director |
SELL
Open market or private sale
|
Indirect |
1,289,434
-99.53%
|
$7,736,604
$6.12 P/Share
|
|
Aug 09
2022
|
Bvf Partners L P Director |
BUY
Conversion of derivative security
|
Direct |
6,863,332
+48.7%
|
-
|
|
Aug 09
2022
|
Bvf Partners L P Director |
SELL
Open market or private sale
|
Direct |
7,210,566
-94.89%
|
$43,263,396
$6.12 P/Share
|
|
Jul 07
2022
|
Michael A Metzger Director |
SELL
Open market or private sale
|
Direct |
20,121
-51.52%
|
$120,726
$6.53 P/Share
|
|
Jul 06
2022
|
Adam R Craig President and CEO |
SELL
Open market or private sale
|
Direct |
18,223
-44.36%
|
$109,338
$6.11 P/Share
|